Author:
Andriulli Angelo,Festa Virginia,Botteri Edoardo,Valvano Maria R.,Koch Maurizio,Bassi Claudio,Maisonneuve Patrick,Sebastiano Pierluigi Di
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Hoffman JP. Status of neoadjuvant therapy for resectable pancreatic cancer. Surg Oncol Clin N Am. 2010;19:411–8.
2. Crane CH, Varadhachary G, Wolff RA, et al. The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20:365–82.
3. Pendurthi TK, Hoffman JP, Ross E, et al. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. Am Surg. 1998;64:686–92.
4. Pingpank JF, Hoffman JP, Ross EA, et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected pancreatic adenocarcinoma of the head of the pancreas. J Gastrointest Surg. 2001;5:121–30.
5. Breslin TM, Hess KR, Harbison DB, et al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol. 2001;8:123–32.
Cited by
161 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献